Skip to content

Search Results

Current Grantees

…Apoptotic Vulnerabilities in Ovarian Cancer Simon Gayther, PhD, Cedars-Sinai Medical Center iPSC Modeling of Ovarian Cancers in BRCA1 and 2 Mutation Carriers 2022 Grant Recipients Jen-Tsan Chi, MD, PhD, Duke…

Rucaparib Extends PFS in Ovarian Cancer

…with BRCA wild-type and loss of heterozygosity high, or LOH high, and the third group with BRCA wild-type and LOH low. Each group was treated with oral rucaparib twice per…

Prevention & Risk

…these can guide you in taking preventive actions. Talk to your doctor if you are concerned about your risk of developing ovarian cancer. Genetic Risk Factors BRCA1 and BRCA2 Genetic…

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.